Status:

COMPLETED

Hormones and Cognition in the Menopausal Transition

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute on Aging (NIA)

Conditions:

Age-associated Memory Impairment

Alteration of Cognitive Function

Eligibility:

FEMALE

40-60 years

Brief Summary

The purpose of this study is to determine if the menopausal transition is associated with subjective and objective cognitive declines that ameliorate in menopause. The investigators hypothesize that p...

Detailed Description

Two groups of women will be recruited, those in early perimenopause and those in mid to late perimenopause. Tests of attention, working memory, mental flexibility, processing speed, and retentive memo...

Eligibility Criteria

Inclusion

  • Menopausal status will be based on self-report of menstrual cycles over the past 12 months. Early perimenopause is defined as the presence of irregular periods (cycle length differs by 7 days from usual). Late perimenopause is defined as at least 2 skipped periods over the past 12 months (cycle double usual length) and one period of amenorrhea (over 60 days without a period), with at least one menstrual cycle over the past 12 months, according to the Stages of Reproductive Aging Workshop criteria.

Exclusion

  • \- history of neurological disease known to affect cognitive function (i.e., stroke, MS, etc) and major psychiatric illness. The investigators will exclude women who are currently pregnant or breast-feeding, have undergone surgical menopause, or who have used exogenous hormone preparations affecting ovarian or pituitary function in the past 3 months. The investigators will also exclude women who have had hysterectomies, but intact ovaries, or oophorectomies. Women who choose to initiate HRT at some point during the study will continue to be followed, but their data obtained after HRT is initiated will be analyzed separately.

Key Trial Info

Start Date :

May 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2016

Estimated Enrollment :

117 Patients enrolled

Trial Details

Trial ID

NCT01429103

Start Date

May 1 2011

End Date

November 1 2016

Last Update

March 1 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester Clinical Research Center

Rochester, New York, United States, 14642